Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
298.66
+1.53 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
945,597
Open
298.51
Bid (Size)
293.55 (1)
Ask (Size)
300.00 (1)
Prev. Close
297.13
Today's Range
294.83 - 299.11
52wk Range
188.53 - 319.74
Shares Outstanding
144,000,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biogen Unusual Options Activity For May 26
May 26, 2023
Via
Benzinga
Analyst Ratings for Biogen
May 23, 2023
Via
Benzinga
Performance
YTD
+9.55%
+9.55%
1 Month
-1.83%
-1.83%
3 Month
+10.94%
+10.94%
6 Month
+2.32%
+2.32%
1 Year
+49.33%
+49.33%
More News
Read More
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $5,500 Today
May 19, 2023
Via
Benzinga
3 Biotech Stocks That Are Revolutionizing Healthcare in 2023
May 19, 2023
Via
InvestorPlace
1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
May 19, 2023
Via
The Motley Fool
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
May 18, 2023
Via
MarketBeat
Exposures
Product Safety
(BIIB) - Analyzing Biogen's Short Interest
May 10, 2023
Via
Benzinga
P/E Ratio Insights for Biogen
May 08, 2023
Via
Benzinga
Elliott Wave Technical Analysis: Biogen Inc. - Monday, May 8
May 08, 2023
Via
Talk Markets
Biogen Unusual Options Activity
May 05, 2023
Via
Benzinga
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease
May 15, 2023
From
Biogen Inc.
Via
GlobeNewswire
Eli Lilly's Alzheimer's Drug Is Just Version 1.0. But It's Still On Track For Blockbuster Status, Analyst Says.
May 15, 2023
Via
Investor's Business Daily
These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win
May 14, 2023
Via
The Motley Fool
3 Reasons to Buy Biogen Stock (and 1 to Sell)
May 12, 2023
Via
The Motley Fool
Here’s What Eli Lilly’s Latest Clinical Win Means For Investors
May 12, 2023
Via
The Motley Fool
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
May 03, 2023
Via
Benzinga
Why Eli Lilly Stock Is Bolting Higher Today
May 03, 2023
Via
The Motley Fool
Biogen Unusual Options Activity For May 03
May 03, 2023
Via
Benzinga
Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal
May 11, 2023
Via
The Motley Fool
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
May 09, 2023
Via
Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
May 04, 2023
Via
Benzinga
Another Sucess In Alzheimer’s Disease
May 03, 2023
Via
Talk Markets
Eli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also Rises
May 03, 2023
Via
Investor's Business Daily
Microsoft, Snap And 2 Other Stocks Insiders Are Selling
May 03, 2023
Via
Benzinga
Biotech Is Back With Guggenheim Upgrade: What You Need To Know
May 01, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.